FDA Leaders Seek Industry Input on ‘Listening Tour’

FDA leaders seek industry input on ‘listening tour’

Commissioner Martin Makary and two of his deputies aim to meet with drugmaker CEOs to discuss how the agency can “modernize” regulations.

In The Headlines: Back to “business as usual” at FDA? - The Cancer Letter

The Oncologic Drugs Advisory Committee held its first session since President Trump’s inauguration, with a two-day, back-to-back marathon meeting, signaling a return to business at FDA after significant upheaval at the agency. This podcast is available on Spotify and Apple Podcasts. In this episode of The Cancer Letter Podcast, Paul Goldberg, editor and publisher of The Cancer Letter and Jacquelyn Cobb, associate editor, talk about Jacquelyn’s …

Cooley Strengthens Life Sciences and Healthcare Regulatory Group With Latest FDA Hire // Cooley // Global Law Firm

FDA Commissioner Launches Magical Mystery Tour to Engage Healthcare Industry Stakeholders

The U.S. Food and Drug Administration (FDA) recently an […] The post FDA Commissioner Launches Magical Mystery Tour to Engage Healthcare Industry Stakeholders first appeared on GeneOnline News. The post FDA Commissioner Launches Magical Mystery Tour to Engage Healthcare Industry Stakeholders appeared first on GeneOnline News.

FDA leadership preps for summer biopharma listening tour across six cities

FDA Commissioner Marty Makary, newly minted CBER chief Vinay Prasad and Principal Deputy Commissioner Sara Brenner are visiting six US cities in June and July to meet with biotech and pharma executives to discuss how ...